MilliporeSigma BioContinuum · 0 reviews

MilliporeSigma BioContinuum

Continuous bioprocessing platform transforming scalable, flexible biopharmaceutical manufacturing

None

— ☆☆☆☆☆ 0 reviews ·

About MilliporeSigma BioContinuum

The MilliporeSigma BioContinuum Platform is a continuous bioprocessing solution designed to revolutionize biopharmaceutical manufacturing across monoclonal antibodies (mAbs), cell therapies, and gene therapies. The platform integrates single-use technologies, advanced automation, and real-time process monitoring to deliver scalability, operational flexibility, and uncompromised product quality. By transitioning from batch to continuous manufacturing, biopharmaceutical producers can achieve higher productivity, reduced capital expenditure, and improved regulatory compliance. AiDOOS enhances BioContinuum deployment through expert governance frameworks, seamless integration with existing manufacturing infrastructure, process optimization consulting, and scalability support across multiple production facilities. The platform's modular architecture supports customized workflows while maintaining validated pharmaceutical manufacturing standards.

Challenges It Solves

Batch processing limitations restrict production capacity and extend time-to-market for critical therapies
High capital costs and operational complexity of traditional bioreactor systems hinder manufacturing scalability
Quality variability and batch-to-batch inconsistencies compromise product efficacy and regulatory approval timelines
Difficulty integrating legacy systems with modern automation and real-time monitoring capabilities
Lengthy process validation and regulatory submissions delay commercialization

Increased production throughput with continuous manufacturing

Reduced capital expenditure through single-use technology

Accelerated regulatory approval and time-to-market

Use Cases

Monoclonal Antibody (mAb) Production

Enables continuous perfusion and fed-batch production of mAbs with superior titer and purity. Reduces batch cycle time from 14-21 days to 3-5 days while maintaining quality standards.

72% Doubled annual production capacity without facility expansion

Cell Therapy Manufacturing

Supports continuous cell culture and expansion workflows for CAR-T and stem cell therapies. Maintains cell viability and potency throughout extended bioprocessing campaigns.

58% Enhanced cell viability and reduced manufacturing costs per dose

Gene Therapy Vector Production

Optimizes continuous production of viral and non-viral vectors with consistent transduction efficiency. Integrates downstream purification for complete end-to-end manufacturing.

65% Improved vector titer and faster patient treatment initiation

Contract Manufacturing Operations (CMO)

Enables CMOs to support multiple biopharmaceutical clients with flexible, campaign-based continuous manufacturing. Reduces campaign setup time and improves equipment utilization.

81% Increased equipment throughput and client production reliability

Rapid Bioprocess Development

Accelerates process development from concept to GMP manufacturing validation. Integrated analytics enable quick protocol iteration and risk-based decision making.

54% Development cycles reduced from 18 months to 8 months

Pricing

Pricing available on request

MilliporeSigma BioContinuum pricing is customized based on your team size, integrations, and requirements. AiDOOS will get you a scoped proposal — for free.

Schedule a Meeting

Key Features

Continuous Bioprocessing Engine

Seamless transition from batch to continuous manufacturing workflows

3-5x higher productivity compared to traditional batch methods

Single-Use Technology Integration

Eliminates cross-contamination risks and reduces cleaning validation burden

90% reduction in facility downtime and cleaning operations

Real-Time Process Monitoring & Analytics

Advanced sensors and data analytics for continuous quality assurance

99.2% product consistency and enhanced regulatory compliance

Automated Control Systems

AI-driven process optimization and self-correcting algorithms

Reduces manual intervention by 75% and human error rates

Scalable Architecture

Modular design supporting multiple production scales and therapies

Deploy across R&D, pilot, and commercial manufacturing seamlessly

Integrated Data Management

Comprehensive digital twin and electronic batch records

Full FDA 21 CFR Part 11 compliance and audit readiness

Reviews

💬

No reviews yet for MilliporeSigma BioContinuum

AiDOOS-verified review data is collected after deployment. Deploy this product and be among the first to share your experience.

Enterprise Readiness

FDA 21 CFR Part 11 Compliance

Role-Based Access Control (RBAC)

Validated Process Controls

Data Encryption & Network Security

Change Management & Traceability

Integrations

7 total apps

Direct integration with industrial control systems for automated process parameter adjustment and real-time equipment feedback

Seamless data exchange for sample tracking, assay results, and automated report generation

Integration with MES platforms for batch tracking, resource scheduling, and production planning

Distributed control system integration enabling comprehensive plant-wide process visibility and optimization

Native support for LabVIEW systems to enable custom analytics and advanced process control algorithms

Integration with enterprise resource planning systems for cost tracking, inventory management, and financial reporting

Digital twin modeling for process optimization and scale-up validation prior to manufacturing

AiDOOS Managed Deployment

Deploy MilliporeSigma BioContinuum in

AiDOOS handles setup, CRM integration, SSO config, and user provisioning. Your team goes live — not your IT department.

—

Deployments

—

Adoption rate

—

Post-deploy sat.

—

Time to value

Prerequisites

Configuration Options

Virtual Delivery Center · A new delivery category

A Virtual Delivery Center for MilliporeSigma BioContinuum

Pre-vetted experts and AI agents in the loop, assembled as a delivery pod. Pay in Delivery Units — universal pricing across roles, seniority, and tech stacks. No hiring, no contracting, no procurement cycle.

Plans from $2,000 — Starter Pack, 10 Delivery Units, 90 days
Refundable on unused Delivery Units, anytime — no questions asked
Re-delivery guarantee on acceptance miss
Pre-flight delivery sizing — you see the plan before you commit

Get a delivery plan for MilliporeSigma BioContinuum What’s a Virtual Delivery Center?

How a Virtual Delivery Center delivers MilliporeSigma BioContinuum

Outcome-based delivery via AiDOOS’s VDC model. Why VDC vs traditional consulting? →

Outcome-Based

Pay for results, not hours

Milestone-Driven

Clear deliverables at each phase

Expert Network

Access to certified specialists

Implementation Timeline

Discover

Requirements & assessment

Integrate

Setup & data migration

Validate

Testing & security audit

Rollout

Deployment & training

Optimize

Performance tuning

Schedule a Meeting

Frequently Asked Questions

What types of biopharmaceutical products can BioContinuum support?

BioContinuum supports monoclonal antibodies (mAbs), recombinant proteins, cell therapies (CAR-T, stem cells), gene therapy vectors, and vaccine production. The modular platform is customizable for diverse bioprocess applications.

How does BioContinuum reduce manufacturing costs compared to batch processing?

Continuous manufacturing reduces batch cycle times by 70-90%, eliminates facility downtime between batches, minimizes single-use consumable waste, and enables higher equipment utilization. Combined with AiDOOS optimization services, total cost of goods sold typically decreases 30-45%.

What is the typical implementation timeline for BioContinuum?

Initial deployment typically requires 6-12 months depending on existing infrastructure. AiDOOS accelerates implementation through pre-configured modules, change management support, and regulatory guidance, reducing time-to-production by 3-4 months.

How does BioContinuum ensure regulatory compliance?

The platform includes validated controls, comprehensive audit trails, electronic batch records with 21 CFR Part 11 compliance, and integrated quality monitoring. AiDOOS provides regulatory consulting to expedite FDA/EMA submissions and inspections.

Can BioContinuum integrate with existing manufacturing systems?

Yes. BioContinuum features open API architecture and supports integration with SCADA, LIMS, MES, and ERP systems. AiDOOS manages integration planning, data mapping, and system validation for seamless deployment.

What ongoing support does AiDOOS provide for BioContinuum?

AiDOOS offers process optimization consulting, advanced analytics services, regulatory compliance updates, scalability planning, and workforce training to maximize ROI and ensure continuous manufacturing excellence.